Country/Region

November 30, 2015

Click Here to Download the Full Report

Despite considerable investments in supply chain reforms, wide-spread medicines stock outs negatively constrain patients’ ability to have access to their medication. Limited availability of antiretroviral drugs (ARVs) caused by dysfunctional supply chains impedes patient initiation and adherence and poses a major barrier to win the global fight against HIV.

A Q&A session with Maryline Mulemba, MSF Head of Mission in Malawi and Testimonies from Antiretrovial Program Patients

 

A decade after MSF started treating people living with HIV in Malawi's Chiradzulu district, it's clear that ARVs and proper care prolong life, prevent new transmissions, and allow people to regain their autonomy.

While gains made in the fight against HIV/AIDS in the past decade are encouraging, countries most affected by the pandemic continue to struggle to place enough people on treatment and implement the best science and strategies to fight the disease.